Andy Murray insists he can still play at a “high level” after stepping up his return to fitness in a defeat against Kyle Edmund at the ‘Battle of the Brits’ event on Wednesday.

Former world number one Murray was playing just his second match since November following a bruised bone.

The two-time Wimbledon champion showed impressive movement and all of his usual tenacity to take the first set, but Edmund hit back to win 6-7, 7-6, 10/5 behind closed doors in Roehampton.

“To be honest, I am not bothered about the results of the match, after a match like that I hope my hip is OK, and I pull up well from it,” Murray said.

“I know if my hip is good, my tennis will only improve and get better over the next few months. If I can get consistent practice.

“That is my hope. The hip feels good. If I play like that and do a few things better, sharpen up a couple of things, I will play high level tennis.

“My groin is a little bit sore today, I felt it in practice and at the beginning of my match, but as the match went on, it felt alright.”

The often-injured Murray plays James Ward in his final group game, needing to win to make it through to the semi-finals.

But the Scot is already looking at the much longer term as he plots a schedule that will see him arrive at the US Open in the best shape.

The three-time Grand Slam champion is likely to return to the ATP Tour at Washington in August.

“I am trying to avoid playing back-to-back events, my priority is to be fit for the grand slams,” Murray said.

“After what I have gone through in the last few years, and not being able to compete at any of the majors, I want to have a few more cracks at them. Get to compete at them. Even if it is for one last time.

“So there would be more chance (of playing) in Washington than Cincinnati - or New York (where the Cincinnati eventy has been moved).”

 

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.